Skip to main navigation Skip to search Skip to main content

Inhaled medicinal cannabis and the immunocompromised patient

  • Rosa Ruchlemer*
  • , Michal Amit-Kohn
  • , David Raveh
  • , Lumír Hanuš
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Abstract

Medicinal cannabis is an invaluable adjunct therapy for pain relief, nausea, anorexia, and mood modification in cancer patients and is available as cookies or cakes, as sublingual drops, as a vaporized mist, or for smoking. However, as with every herb, various microorganisms are carried on its leaves and flowers which when inhaled could expose the user, in particular immunocompromised patients, to the risk of opportunistic lung infections, primarily from inhaled molds. The objective of this study was to identify the safest way of using medicinal cannabis in immunosuppressed patients by finding the optimal method of sterilization with minimal loss of activity of cannabis. We describe the results of culturing the cannabis herb, three methods of sterilization, and the measured loss of a main cannabinoid compound activity. Systematic sterilization of medicinal cannabis can eliminate the risk of fatal opportunistic infections associated with cannabis among patients at risk.

Original languageEnglish
Pages (from-to)819-822
Number of pages4
JournalSupportive Care in Cancer
Volume23
Issue number3
DOIs
StatePublished - Mar 2015

Bibliographical note

Publisher Copyright:
© 2014, Springer-Verlag Berlin Heidelberg.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Aspergillosis
  • Cannabis
  • Immunocompromised host

Fingerprint

Dive into the research topics of 'Inhaled medicinal cannabis and the immunocompromised patient'. Together they form a unique fingerprint.

Cite this